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Abstract
Glucagon like peptide-1 (GLP-1) is released from intestinal L-cells in response to nutrient ingestion and acts upon pancreatic
b-cells potentiating glucose-stimulated insulin secretion and stimulating b-cell proliferation, differentiation, survival and
gene transcription. These effects are mediated through the activation of multiple signal transduction pathways including
the extracellular regulated kinase (ERK) pathway. We have previously reported that GLP-1 activates ERK through a
mechanism dependent upon the influx of extracellular Ca2+ through L-type voltage gated Ca2+ channels (VGCC). However,
the mechanism by which L-type VGCCs couple to the ERK signalling pathway in pancreatic b-cells is poorly understood. In
this report, we characterise the relationship between L-type VGCC mediated changes in intracellular Ca2+ concentration
([Ca2+]i) and the activation of ERK, and demonstrate that the sustained activation of ERK (up to 30 min) in response to GLP-1
requires the continual activation of the L-type VGCC yet does not require a sustained increase in global [Ca2+]i or Ca
2+ efflux
from the endoplasmic reticulum. Moreover, sustained elevation of [Ca2+]i induced by ionomycin is insufficient to stimulate
the prolonged activation of ERK. Using the cell permeant Ca2+ chelators, EGTA-AM and BAPTA-AM, to determine the spatial
dynamics of L-type VGCC-dependent Ca2+ signalling to ERK, we provide evidence that a sustained increase in Ca2+ within
the microdomain of the L-type VGCC is sufficient for signalling to ERK and that this plays an important role in GLP-1-
stimulated ERK activation.
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Introduction
GLP-1 is a hormone secreted from intestinal L-cells in
response to nutrients (for reviews see [1,2]). The primary site
of GLP-1 action is the pancreatic b-cell where it stimulates
proliferation, differentiation, insulin gene transcription, and the
potentiation of glucose-dependent insulin secretion. These effects
are mediated through the activation of the GLP-1 receptor
(GLP-1R), a Gas-protein coupled receptor of the secretin/
glucagon type B family. GLP-1R agonists stimulate an increase
in the production of cAMP, which potentiates glucose-stimulated
rises in intracellular free [Ca2+] ([Ca2+]i), and thus insulin
secretion through a number of mechanisms including the
inactivation of K+ATP channels. GLP-1 also potentiates glu-
cose-stimulated ERK activation [3–7], and importantly the
activation of ERK has been shown to play a positive role in the
stimulation of pancreatic b-cell proliferation, differentiation,
survival and insulin gene transcription [7–9]. Furthermore, in
the pancreatic b-cell line MIN6 (mouse insulinoma 6), glucose-
induced ERK1/2 activation enhances insulin secretion via the
phosphorylation of synapsin I [10].
We have previously reported that GLP-1-stimulated ERK
activation in b-cells is dependent on the influx of Ca2+ through the
L-type VGCC, as nifedipine, an L-type VGCC blocker, effectively
inhibits GLP-1-induced ERK activation [4]. Moreover, other
agents that activate L-type VGCCs, such as glucose, depolarising
concentrations of K+ or Bay-K 8644, an L-type VGCC agonist, all
lead to the activation of ERK via a nifedipine-sensitive pathway
[3–6,11]. However, the mechanism by which GLP-1 signals to
ERK via the L-type VGCC is unknown.
In this report, we provide evidence that, in the pancreatic b-cell
line Mouse insulinoma-6 cells (MIN6 cells) [12], GLP-1 stimulates
ERK phosphorylation through a mechanism requiring the
sustained activation of L-type VGCCs but which does not require
a sustained global increase in [Ca2+]i. Instead, we show that a
sustained increase in [Ca2+] within the microdomain of the L-type
VGCC is sufficient for L-type VGCC signalling to ERK activation
and plays an important role in the sustained phase of ERK
activation in response to GLP-1.
Results
GLP-1 stimulated ERK activation requires L-type VGCC
activation
GLP-1 signalling to ERK was characterised in the pancreatic
b-cell line MIN6 [12]. Cells were incubated with 16.7 mM
glucose in the presence and absence of 10 nM GLP-1 for up to
30 min and changes in the phosphorylation status of ERK were
determined as an index of ERK activation. As previously
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reported [4], glucose led to an increase in ERK activation, which
was potentiated by GLP-1 (Figure 1a). To confirm the
dependency of GLP-1-stimulated ERK phosphorylation on L-
type VGCC channel activation, MIN6 cells were treated with
glucose plus GLP-1 for up to 30 min in the presence or absence
of the L-type VGCC blocker, nifedipine (Figure 1b). GLP-1 plus
glucose treatment of MIN6 cells resulted in the rapid
phosphorylation of ERK that remained elevated for the duration
of the experiment. These increases in ERK phosphorylation
were inhibited by nifedipine at all time points tested. Similar
results were obtained using another L-type VGCC blocker
dilitiazem (Figure 1c). These results confirm that in MIN6 cells,
GLP-1-stimulated ERK phosphorylation in the presence of an
elevated concentration of glucose requires L-type VGCC
Figure 1. GLP-1-stimulated ERK activation requires L-type VGCC activation. a) MIN6 cells were preincubated for 1 h in KRB supplemented
with 1 mM glucose. Cells were then incubated in 16.7 mM glucose in the absence or presence of 10 nM GLP-1. Proteins were resolved by SDS-PAGE
and Western blotted using anti-phospho-ERK1/2 (pERK) or anti-ERK2 (ERK2) antibodies. A representative blot is shown above densitometric analysis
of the results showing mean +S.E.M. (n = 5). All statistical comparisons were by one-way ANOVA with Bonferroni’s multiple comparison test compared
to glucose alone at each time point; *, P,0.05; **, P,0.01; ***, P,0.001. b) MIN6 cells were preincubated for 1 h in KRB supplemented with 1 mM
glucose. Cells were stimulated with 10 nM GLP-1 plus 16.7 mM glucose in the presence or absence of 10 mM nifedipine for the times indicated.
Proteins were resolved by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 and anti-ERK2 antibodies. A representative blot is shown above
densitometric analysis of the results showing mean +S.E.M. (n = 3). All statistical comparisons were by one-way ANOVA with Bonferroni’s multiple
comparison test compared to GLP-1 plus glucose at each time point; *, P,0.05; **, P,0.01; ***, P,0.001. c) MIN6 cells were preincubated for 1 h in
KRB supplemented with 1 mM glucose. Cells were stimulated with 10 nM GLP-1 plus 16.7 mM glucose in the presence or absence of 50 mM
dilitiazem for the times indicated. Cell lysates were analysed by SDS-PAGE and Western blotting using anti-phospho-ERK1/2 or anti-ERK2 antibodies.
A representative blot is shown above densitometric analysis of the results 6 S.E.M. All statistical comparisons were by one-way ANOVA with
Bonferroni’s multiple comparison test compared to glucose plus GLP1; *, P,0.05; **, P,0.01; (n = 3). d) MIN-6 cells were loaded with fura-2-AM and
[Ca2+]i levels measured using epifluorescence microscopy. i) Representative traces from single cells incubated with 1 mM glucose (control), 16.7 mM
glucose (glucose), 10 nM GLP-1 plus 16.7 mM glucose (GLP-1/glucose) or 10 nM GLP-1 plus 16.7 mM glucose in the presence of 10 mM nifedipine
(GLP-1/glucose + nifedipine). ii) Area under the curve (A.U.C.) across the 30 min stimulation showing mean +S.E.M. (n.30). Statistical comparisons
were by one-way ANOVA with Dunnett’s range test compared to GLP-1 plus glucose; ***, P,0.001. e) Membrane potential recordings from MIN6 cells
recorded in the perforated-patch, current-clamp mode. i) The effect of addition of 10 nM GLP-1 plus 16.7 mM glucose on membrane potential. ii) A
membrane potential recording after 5.5 min in the continuous presence of 10 nM GLP-1 and 16.7 mM glucose. iii) After 10 min in the presence of
10 nM GLP-1 and 16.7 mM glucose, the effect on excitability of bath application of nifedipine (10 mM) was recorded.
doi:10.1371/journal.pone.0033004.g001
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activation. In order to investigate the temporal correlation of
GLP-1 plus glucose-stimulated L-type VGCC-dependent ERK
activation with increases in [Ca2+]i, changes in [Ca
2+]i were
assessed by single-cell epifluorescence microscopy in response to
glucose, GLP-1 plus glucose or GLP-1 plus glucose in the
presence of nifedipine. Application of 16.7 mM glucose alone
caused a rise in [Ca2+]i initiating approximately 5 min after
application which, like ERK activation, was potentiated by
10 nM GLP-1 (Figure 1d). The co-application of nifedipine
blocked GLP-1 plus glucose stimulated increases in [Ca2+]i
(Figure 1d). Using an electrophysiological approach, we also
show that GLP-1 plus glucose application caused membrane
depolarisation (to 22162 mV from 262.562.2 mV; n =
17.cells) and action potential firing (figure 1e i and ii).
Application of nifedipine did not cause membrane repolarization
but did cause a loss of action potential firing (Figure 1e iii). This
is consistent with recordings form human pancreatic b-cells in
which a Ca2+ channel blocker, isradipine, caused action
potential failure [13]. These data provide evidence that the
activation of L-type VGCCs play an important role in the
membrane excitability and that increases in [Ca2+]i coincide
with increased ERK phosphorylation.
The sustained activation of L-type VGCCs is required for
the sustained activation of ERK
To determine whether the sustained activation of L-type
VGCCs is required for the sustained activation of ERK, MIN6
cells were treated with GLP-1 plus glucose in the presence or
absence of nifedipine for up to 30 min. Nifedipine was applied to
the cells at the same time as GLP-1 or 10 and 20 min post-GLP-1
plus glucose treatment and incubated for up to 30 minutes
(Figure 2). GLP-1 plus glucose led to an increase in ERK
phosphorylation which was inhibited by nifedipine at all times
post-nifedipine application (Figure 2). These results demonstrate
that the sustained activation of L-type VGCCs is required for the
sustained activation of ERK.
The role of intracellular Ca2+ stores in GLP-1-stimulated
ERK activation
Our data indicate that increases in [Ca2+]i, mediated by the
influx of Ca2+ though L-type VGCC are necessary for GLP-1 plus
glucose-stimulated ERK activation. However, it is also possible
that ERK activation is mediated by Ca2+ induced Ca2+ release
(CICR) from intracellular stores triggered by Ca2+ entry through
L-type VGCCs. Indeed, it has been reported that glucose plus-
GLP-1-stimulated ERK activation in INS-1 cells is dependent
upon CICR [3,14]. To investigate the role of endoplasmic
reticulum (ER) Ca2+ stores in GLP-1 plus glucose-stimulated
ERK activation, MIN6 cells were pre-incubated with ryanodine,
to inhibit ryanodine receptors and thus CICR, or thapsigargin to
inhibit ER Ca2+-ATPase and to cause ER store depletion
(Figure 3). The cells were then incubated with 10 nM GLP-1
plus 16.7 mM glucose. However, these inhibitors had no
significant effect on the GLP-1 plus glucose-stimulated ERK
phosphorylation over the 30 min time-course of the experiment
(Figure 3a). The effectiveness of the thapsigargin and ryanodine in
blocking IP3 and RyR dependent Ca
2+ efflux respectively from
ER-Ca2+ stores was confirmed using either carbachol, which
robustly stimulates IP3-dependent release of Ca
2+ from intracel-
lular stores via activation of the muscarinic M3 receptor [15]
(Figure 3c) or caffeine which stimulates Ca2+ release via activation
of the RyR [16] (Figure 3b). These data provide evidence that
Ca2+ release from the ER is not essential for L-type VGCC
signalling to ERK in MIN6 cells.
A sustained increase in [Ca2+]i is insufficient for the
sustained activation of ERK
Our data indicate that there is a temporal correlation between
an elevation in [Ca2+]i via L-type VGCC activation and ERK
phosphorylation. Therefore, it is possible that the sustained L-type
VGCC-dependent phosphorylation of ERK, observed upon
depolarisation, is due to the long-lasting current maintained by
this channel and thus its ability to maintain sustained elevations in
Figure 2. The sustained activation of L-type VGCCs is required for the sustained activation of ERK. MIN6 cells were preincubated for 1 h
in KRB supplemented with 1 mM glucose. The cells were then incubated in KRB containing 10 nM GLP-1 and 16.7 mM glucose in the absence or
presence of 10 mM nifedipine applied at either 0, 10 or 20 min post-GLP-1/glucose addition. Proteins were resolved by SDS-PAGE and Western
blotted using anti-phospho-ERK1/2 (pERK) and anti-ERK2 (ERK2) antibodies. A representative blot is shown with densitometric analysis of the results
below showing mean +S.E.M. (n = 3). Results were analysed using two-way ANOVA with Bonferroni’s multiple comparison test compared to GLP-1
plus glucose; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0033004.g002
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[Ca2+]i (Figure 2). Indeed, an elevation in extracellular potassium
results in the robust increase in [Ca2+]i and the activation of ERK,
which are blocked by nifedipine (figure 4a and b). However, to
investigate whether sustained increases in [Ca2+]i, independent of
L-type VGCC activation, are sufficient for sustained ERK
activation, we chronically elevated [Ca2+]i by treating the cells
with ionomycin, a Ca2+ ionophore. Although ionomycin caused a
sustained elevation of [Ca2+]i (Figure 4c), it was unable to induce
the sustained activation of ERK (Figure 4d). However, ionomycin
was able to cause the transient phosphorylation of ERK (Figure 4d)
but the intensity of this phosphorylation was substantially less than
that seen in response to elevated extracellular concentration of K+
(50 mM), which caused a much lower increase in [Ca2+]i through
membrane depolarisation and L-type VGCC channel activation
(Figure 4). These data provide evidence that L-type VGCC
signalling to ERK occurs via a mechanism that is not solely
dependent upon the sustained global increase in [Ca2+]i but is
integrally linked to the activation of L-type VGCCs.
Local Ca2+ influx within the microdomain of the L-type
VGCC is sufficient to activate ERK
To further investigate how L-type VGCCs signal to ERK,
MIN6 cells were incubated with Bay-K 8644, an activator of the
L-type channel, and changes in the phosphorylation of ERK and
Figure 3. The role of intracellular Ca2+ stores in GLP-1-stimulated ERK activation. a) MIN6 cells were either pre-incubated in KRB
supplemented with 1 mM glucose in the absence (control) or presence of 100 mM ryanodine or 1 mM thapsigargin for 30 min prior to treatment with
10 nM GLP-1 plus 16.7 mM glucose for the times indicated. Where indicated, cells were also treated with 16.7 mM glucose alone. Proteins were
separated by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 (pERK) and anti-ERK1/2 (ERK1/2) antibodies. A representative blot is shown
with densitometric analysis of the results below showing mean +S.E.M. (n = 3). Data were analysed by two-way ANOVA with Bonferroni’s multiple
comparison test compared to GLP-1 plus glucose at each time point. No significant differences were observed. b) MIN6 cells incubated in the absence
of extracellular Ca2+ calcium were preincubated without or with 100 mM ryanodine for 30 min prior to the addition 10 mM caffeine. Changes in
fluorescence as an index of [Ca2+]i were determined in fluo-4-loaded cells using a NOVOstar platereader. c) MIN6 cells incubated in the absence of
extracellular Ca2+ were pretreated without or with 1 mM thapsigargin for 30 min prior to the addition 100 mM carbachol (Carb.) . Changes in [Ca2+]i
were determined in fluo-4-loaded cells using a NOVOstar platereader ***, P,0.001 by Student’s t test.
doi:10.1371/journal.pone.0033004.g003
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[Ca2+]i were determined (Figure 5). Bay-K 8644 stimulated the
sustained activation of ERK (for up to 30 min) (Figure 5a) yet
caused no significant increase in global [Ca2+]i (Figure 5b) . The
reason Bay-K 8644 does not cause an increase in global [Ca2+]i is
that under the conditions used in these experiments (i.e. at low
glucose concentration) the open probability of the channel is low
and therefore Bay-K 8644 only increases the open probability of a
small proportion of L-type VGCCs. These results suggests that a
local increase in [Ca2+]i within the vicinity of the L-type VGCC is
sufficient to couple to the ERK signalling pathway. To explore this
Figure 4. A sustained global increase in [Ca2+]i is insufficient for the prolonged activation of ERK. (a and b) MIN6 cells were preincubated
for 1 h in KRB supplemented with 1 mM glucose. Cells were incubated in 50 mM K+ (K50) in the presence or absence of 10 mM nifedipine for the
times indicated (All statistical comparisons were by one-way ANOVA with Bonferroni’s multiple comparison test compared to K50 at each time point;
*, P,0.05; **, P,0.01; ***, P,0.001). a) Proteins were resolved by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 and anti-ERK2
antibodies. A representative blot is shown above densitometric analysis of the results showing mean +S.E.M. (n = 3). b) In cells loaded with 2 mM fluo-
4-AM, fluorescence (as an index of [Ca2+]i) was measured using a NOVOstar platereader. (c and d) MIN6 cells were preincubated for 1 h in KRB
supplemented with 1 mM glucose. Cells were then treated with 10 mM ionomycin or 50 mM K+ (K50) for the times indicated. c) In cells loaded with
2 mM fluo-4-AM, fluorescence (as an index of [Ca2+]i) was measured using a NOVOstar platereader. ***, P,0.001 for K50 versus ionomycin at
equivalent time points. d) After treatments, proteins were resolved by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 (pERK) or anti-ERK2
(ERK2) antibodies. A representative blot is shown with densitometric analysis of the results below showing mean +S.E.M. (n = 3).
doi:10.1371/journal.pone.0033004.g004
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possibility, MIN6 cells were loaded with BAPTA-AM or EGTA-
AM that differ in their rate of Ca2+ binding and can reveal
information regarding the spatial dynamics of Ca2+ signalling
(i.e. BAPTA buffers bind and release Ca2+ ions approximately
50–400 times faster than EGTA and thus rapidly buffer potential
increases in Ca2+ at the site of entry) [17–21]. When MIN6 cells
were treated with Bay-K 8644, the phosphorylation of ERK was
unaffected by EGTA-AM but abolished by BAPTA-AM
(Figure 5a). This provides evidence that local Ca2+, predicted
to be within 20 nm of the site of Ca2+ entry (i.e. the L-type
VGCC) [22], is sufficient to activate ERK in response to Bay-K
8644.
Local Ca2+ influx within the microdomain of the L-type
VGCC mediates the sustained GLP-1-stimulated
activation of ERK
To investigate whether the GLP-1 plus glucose-stimulated ERK
activation was also dependent upon local increases in [Ca2+],
MIN6 cells were incubated with BAPTA-AM or EGTA-AM prior
Figure 5. L-type VGCC activation is sufficient to mediate sustained ERK activation in MIN6 cells via local Ca2+ signalling. MIN6 cells
incubated in KRB plus 2 mM glucose were loaded with 100 mM of EGTA-AM or BAPTA-AM prior to treatment with 10 mM Bay-K 8644 at room
temperature for the times indicated. a) Proteins were resolved by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 (pERK) or anti-ERK2
(ERK2) antibodies. A representative blot is shown with densitometric analysis of the results below showing mean +S.E.M. (n = 4). Results were
analysed by two-way ANOVA with Bonferroni’s multiple comparison test compared to Bay-K 8644 alone at each time point; ***, P,0.001. b) MIN6
cells were treated as in (a) but in addition were loaded with 2 mM fura-2-AM and [Ca2+]i levels measured by epifluorescence microscopy (n.30). A
mean trace is shown. In addition, a representative trace obtained from MIN6 cells stimulated with 10 nM GLP-1 plus 16.7 mM glucose was included
for comparison.
doi:10.1371/journal.pone.0033004.g005
L-Type VGCC Signalling to ERK
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33004
to GLP-1 plus glucose treatment (Figure 6). GLP-1 plus glucose-
stimulated increases in global [Ca2+]i were effectively buffered by
either BAPTA-AM or EGTA-AM (Figure 6b). In addition, GLP-1
plus glucose-stimulated phosphorylation of ERK at 5 and 30 min
was completely inhibited by BAPTA-AM, demonstrating that this
ERK phosphorylation is dependent upon Ca2+. However, in the
presence of EGTA-AM, GLP-1 plus glucose-stimulated ERK
phosphorylation at 5 min, although significantly inhibited, re-
mained elevated. In contrast, GLP-1 plus glucose-stimulated ERK
phosphorylation was unaffected at 30 min (Figure 6a). This
indicates that the sustained activation of ERK (30 min) is likely
mediated by increased local [Ca2+] at the site of entry (i.e. L-type
VGCCs) whereas the acute activation of ERK is mediated by both
local and global rises in [Ca2+].
Discussion
The present study shows that GLP-1 plus glucose-stimulated
ERK activation in pancreatic b-cells is dependent upon the influx
of Ca2+ through L-type VGCC (Figure 1) and that the sustained
activation of the L-type VGCC is critical for the sustained
activation of ERK (Figure 2), demonstrating that the two
processes are tightly coupled. Although, the sustained activation
of L-type VGCCs leads to a sustained rise in the [Ca2+]i
(Figure 2), global elevations in [Ca2+]i alone are insufficient to
induce the sustained activation of ERK (Figure 4). Interestingly,
pharmacological activation of the L-type VGCC using Bay-K
8644 is able to robustly activate ERK via a Ca2+-dependent
mechanism but under the non-polarising conditions used in these
experiments is unable to stimulate global increases in [Ca2+]i
(Figure 5). Using BAPTA-AM and EGTA-AM to explore the
spatial dynamics of Ca2+ signalling to ERK in response to Bay-K
8644, we provide evidence that a local rise in [Ca2+] within the
microdomain of the L-type VGCC is sufficient to activate ERK
(Figure 5). Furthermore, our results show that local increases in
[Ca2+] within the microdomain of the L-type VGCC are also
important in GLP-1 plus glucose signalling to ERK (Figure 6). In
this context, both global and local Ca2+ signalling to ERK is
required for the acute activation of ERK (5 min post-GLP-1 plus
glucose stimulation) whereas local increases in [Ca2+] are
responsible for the prolonged activation of ERK (30 min post-
GLP-1 plus glucose stimulation). This indicates that there are two
mechanistically distinct phases of ERK activation. Interestingly,
two phases of ERK activation in response to GLP-1 plus glucose
have been reported previously: a PKA-dependent pathway
mediating rapid and transient ERK1/2 phosphorylation and a
second b-arrestin 1-dependent phase [23].
In cultured cortical neurones, the L-type VGCC has been
implicated in the activation of ERK via a mechanism that requires
calmodulin (CaM) binding to the a1c (CaV1.2) pore forming
subunit of the channel [24]. CaM is thought to bind to a motif on
the C-terminal tail of the Cav1.2, the LA motif, within the pore of
the a1 subunit in a Ca2+-independent fashion [25]. Upon
membrane depolarisation and the opening of L-type VGCC, the
increase in [Ca2+] activates the bound CaM, which is then
displaced from the LA motif and re-binds to a second Ca2+-CaM
binding site (the IQ motif) within the intracellular C-terminal tail
of the channel [25]. The bound CaM then either directly activates
other signalling molecules and/or causes a conformational change
in the channel, which helps it recruit and perhaps activate other
signalling molecules [24]. Interestingly, GLP-1 plus glucose-
mediated ERK activation in b-cells is also dependent on CaM
as W7, a competitive inhibitor of CaM, prevents activation in
MIN6 and INS-1E cells [3,4]. Therefore, the mechanism by which
L-type VGCC activation leads to ERK activation in pancreatic b-
cells is likely to be similar to that observed in neurones.
There are several downstream effectors of CaM, which may in
turn activate ERK indirectly, including the CaM kinases, CaMKII
and IV [26] . Indeed, there are a number of reports that show that
the CaMKII inhibitors KN62 and KN93 prevent GLP-1 plus
glucose-mediated ERK activation in pancreatic b-cells [3,4].
However, these compounds have been reported to also inhibit
voltage-dependent channels [27] and therefore any conclusions
reached using these inhibitors should be treated with caution.
More recently, calcineurin has been implicated in the activation of
ERK in response to glucose in b-cells and intriguingly its activity is
also regulated by CaM [28].
Insulin secretion also depends upon a localized increase in
[Ca2+] close to the VGCCs [29,30]. The localization of secretory
granules close to VGCCs guarantees that granules are exposed to
a very high [Ca2+], thus ensuring that exocytosis is triggered by the
localized increases in [Ca2+]i evoked by an action potential.
Functional studies using dihydropyridine resistant a1D and a1C
channels expressed in pancreatic b-cells indicate that GLP-1
potentiation of glucose-induced insulin secretion is preferentially
coupled to the a1D channel in INS-1 cells via a mechanism that
requires the activation of ERK1/2 [31].
In conclusion, we show that that the sustained activation of
ERK in response to GLP-1 in the presence of an elevated glucose
concentration requires the continual activation of the L-type
VGCC yet does not require a sustained increase in global [Ca2+]i
or Ca2+ efflux from the ER. Interestingly, based on the studies
with BAPTA-AM and EGTA-AM, we provide evidence that
elevation of [Ca2+]i within 20 nm of the site of entry through L-
type VGCCs is sufficient for ERK activation and plays an
important role in ERK activation in response to GLP-1.
Materials and Methods
Chemicals
Nifedipine, dantrolene, ryanodine and thapsigargin were
purchased from Calbiochem (CA, USA). Ionomycin was pur-
chased from Tocris Bioscience (Bristol, UK). EGTA-AM and
BAPTA-AM were purchased from Invitrogen (Paisley, UK). All
other chemicals (unless stated) were obtained from Sigma-Aldrich
(Poole, UK).
Cell Culture
Mouse Insulinoma-6 cells (MIN6 cells) [12] (kindly provided by
Prof. Jun-Ichi Miyazaki) were used between passages 25–40 at
,80% confluence and grown as described previously [32].
Cell Treatments
Prior to treatment, the medium was removed and cells washed
twice with HEPES-buffered Krebs-Ringer bicarbonate (KRB)
(115 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 2.5 mM MgCl2,
2.5 mM CaCl2, 20 mM HEPES, pH 7.4). The cells were then
incubated for 1 h at 37uC in KRB containing 1 mM glucose prior
to treatments for the times indicated. All treatments were stopped
by the addition of ice cold lysis buffer (1% Triton, 10 mM b-
glycerophosphate, 50 mM Tris-HCl, pH7.5, 1 mM EDTA, 1 mM
EGTA, 1 mM sodium orthovanadate, 1 mM benzamidine HCl,
0.2 mM phenylmethylsulfonyl fluoride, 1 mg/ml each of leupeptin
and pepstatin, 0.1% b-mercaptoethanol, and 50 mM sodium
fluoride). The lysates were then centrifuged for 10 min at
16,0006g, supernatants kept, and total protein concentrations
determined by the Bradford assay (Bio-Rad (CA, USA)). The
protein lysates were stored at {80uC until further analysis.
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Figure 6. GLP-1-stimulated ERK activation in MIN6 cells is mediated via local Ca2+ signalling. MIN6 cells incubated in KRB plus 1 mM
glucose were loaded with 100 mM EGTA-AM or BAPTA-AM at room temperature prior to treatment with 10 nM GLP-1 plus 16.7 mM glucose for the
times indicated. a) Proteins were resolved by SDS-PAGE and Western blotted using anti-phospho-ERK1/2 (pERK) and anti-ERK2 (ERK2) antibodies. A
representative blot is shown with densitometric analysis of the results below showing mean +S.E.M. (n = 3). Data were analysed by two-way ANOVA
with Bonferroni’s multiple comparison test compared to GLP-1 plus glucose at each time point; *, P,0.05; **, P,0.01; ***, P,0.001. b) MIN6 cells were
treated as in a) but in addition, loaded with 2 mM fura-2-AM and [Ca2+]i levels measured by epifluorescence microscopy. i) The mean increase in
[Ca2+]i represented as area under the curve (A.U.C.) during ii) 10 min or iii) 30 min stimulation, mean +S.E.M. (n.30). Statistical comparisons were by
one-way ANOVA with Dunnett’s range test compared to GLP-1 plus glucose in the absence of chelator. ***, P,0.001.
doi:10.1371/journal.pone.0033004.g006
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SDS-Polyacrylamide Gel Electrophoresis (PAGE) and
Immunoblotting
SDS-PAGE and Western blotting were performed as previously
described [32]. Rabbit anti-phospho-ERK1/2 antibody (recog-
nizing only the phosphorylated (activated) forms of ERK) and anti-
ERK2 antibody were purchased from New England Biolabs
(Hitchin, UK). Detection was by horseradish peroxidase-linked
anti-rabbit secondary antibodies and enhanced chemilumines-
cence (GE healthcare, (Bucks, UK)).
Single Cell Ca2+ Imaging
For Ca2+ imaging, MIN6 cells were loaded with 2 mM fura-2-
acetoxymethyl ester (fura-2-AM), prepared in dye-loading buffer
(KRB supplemented with 1 mg/ml bovine serum albumin (BSA)
and 0.1% Pluronic F-127) for 30 min at 20uC. The cells were then
washed and further incubated for 10 min in KRB to allow de-
esterification of the indicator. Changes in fluorescence were
monitored using a Nikon Diaphot 200 inverted epifluorescence
microscope with an oil immersion objective (406) and a Spectra-
MASTER II module (PerkinElmer Life and Analytical Sciences,
Waltham, MA). Cells were excited alternatively with light at
340 nm and 380 nm with emission detected at 510 nm. Raw
fluorescence data were exported to Microsoft Excel and expressed
as the 340/380 ratio for each cell and further analysed in
GraphPad Prism. A ratio value was collected each 2 s. Data are
reported as either the 340/380 ratio (R) or R/R0 where R0 is the
basal (unstimulated) ratio.
Population NOVOstar [Ca2+]i measurement
Population-based Ca2+ fluorescence measurements were per-
formed using a NOVOstar microplate reader (BMG LabTechnol-
ogies, Offenburg, Germany) equipped with a pipettor and 2
injectors. MIN6 cells in a 96-well plate format were washed twice
with KRB buffer then loaded with 2 mM fluo-4-AM as described
above. Cells were washed with KRB after fluo-4-AM loading.
Details of treatments are provided in the figure legends. Fluo-4 was
excited using a high energy xenon flash lamp through a 485 nm
filter and emission detected by a photomultiplier after passing
through a 520 nm filter. Measurements were collected at 2 s
intervals. Raw fluorescence data were exported to Microsoft Excel
and expressed as F/Fo (stimulated fluorescence/basal fluorescence)
and further analysed in GraphPad Prism. A single well of cells
without fluo-4-AM loading was used as an auto-fluorescence
control and subtracted from the fluorescence values obtained.
Data are reported as the average of at least three independent
experiments 6 S.E.M..
Electrophysiology
MIN6 cells were preincubated for 1 h in KRB buffer prior to
electrophysiological measurements. Membrane potential was
recorded using an Axopatch 200 amplifier (Axon Instruments
(CA, USA)). Signals were digitized using a DIGIDATA 1322A
interface, and records acquired and analysed using pClamp9.2
software (Axon Instruments (CA, USA)). All electrophysiological
recordings were made at 28uC using the perforated-patch, whole-
cell configuration. Patch pipettes (3–5 MV) were made from thick-
walled borosilicate glass. Pipettes were initially dipped in a solution
containing: 76 mM K2SO4, 10 mM NaCl, 10 mM KCl, 1 mM
MgCl2, and 5 mM HEPES (pH 7.35 with KOH) and then back-
filled with the same solution including amphotericin B (240 mg/
ml). The bath solution contained: 140 mM NaCl, 3.6 mM KCl,
2 mM NaHCO3, 0.5 mM NaH2PO4, 0.5 mM MgSO4, 2.6 mM
CaCl2, 5 mM HEPES and 2.5 mM D-glucose (pH 7.4 with
NaOH).
Statistical Analysis
Statistical differences between multiple groups were analysed by
either one-way or two-way analysis of variance (ANOVA),
followed by post-hoc analysis. Comparison between two sets of
data have been analysed by Student’s t-test. Statistical analyses
were performed in GraphPad Prism and significance was only
confirmed when p,0.05.
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